The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective. Herein, we investigated the clinical value and functions of adiponectin receptors (AdipoR1 and AdipoR2) in metastatic renal cell carcinoma (...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neoplasia
Auteurs principaux: Sun, Guangxi, Zhang, Xingming, Liu, Zhenhua, Zhu, Sha, Shen, Pengfei, Zhang, Haoran, Zhang, Mengni, Chen, Ni, Zhao, Jinge, Chen, Junru, Liu, Jiandong, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Wang, Yufang, Zeng, Hao
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press 2019
Sujets:
Original article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700451/
https://ncbi.nlm.nih.gov/pubmed/31401413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.07.004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires